F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
26/08/2026-18:23 26/08/2026-18:35 חדשות NYT דיווח
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.